Lipotecan (TLC388) / Taiwan Liposome Company  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Lipotecan (TLC388) / Taiwan Liposome Company
NCT00747474: Phase I Study of Intravenous Lipotecan® (TLC388 HCl for Injection) in Patients With Advanced Solid Tumors

Completed
1
54
US, RoW
Lipotecan, Lipotecan (TLC388)
Taiwan Liposome Company
Advanced Solid Tumors
08/11
12/11

Download Options